Establishment Labs Holdings (ESTA) Interest Coverage Ratio (2017 - 2026)
Establishment Labs Holdings' (ESTA) quarterly Interest Coverage Ratio came in at 0.33 in Q1 2026, up 88.53% year-on-year from 0.18 in Q1 2025, and up 76.01% quarter-over-quarter from 1.38 in Q4 2025.
Establishment Labs Holdings (ESTA) Interest Coverage Ratio (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' Interest Coverage Ratio history runs 10 years deep, the most recent figure standing at 0.33 for Q1 2026.
- On a quarterly basis, Interest Coverage Ratio rose 88.53% year-over-year to 0.33 in Q1 2026; TTM through Mar 2026 was 1.46, a 45.46% increase from a year earlier, with the FY2025 full-year figure at 1.09, up 54.14% from the prior year.
- Interest Coverage Ratio climbed to 0.33 in Q1 2026 per ESTA's latest filing, from 1.38 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 1.79 in Q4 2022 and bottomed at 5.72 in Q3 2023.
- The 5-year median for Interest Coverage Ratio is 2.17 (2023), against an average of 2.12.
- Across the five-year window, Interest Coverage Ratio surged 144.41% in 2022 and plunged 197.39% in 2023, its largest moves.
- Year by year, Interest Coverage Ratio stood at 1.79 in 2022, then tumbled by 197.39% to 1.74 in 2023, then slumped by 128.7% to 3.98 in 2024, then soared by 65.24% to 1.38 in 2025, then surged by 76.01% to 0.33 in 2026.
- Per Business Quant, the three latest ESTA Interest Coverage Ratio figures stand at 0.33 (Q1 2026), 1.38 (Q4 2025), and 0.65 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.90 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 13.19 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.15 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.19 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 82.35 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -2.90 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 5.36 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Establishment Labs Holdings | 2.73 Bn | 2.66 Bn | 42.34 Mn | -0.33 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.33 |
| Dec 31, 2025 | -1.38 |
| Sep 30, 2025 | -0.65 |
| Jun 30, 2025 | -1.02 |
| Mar 31, 2025 | -2.90 |
| Dec 31, 2024 | -3.98 |
| Sep 30, 2024 | -2.19 |
| Jun 30, 2024 | -1.80 |
| Mar 31, 2024 | -2.02 |
| Dec 31, 2023 | -1.74 |
| Sep 30, 2023 | -5.72 |
| Jun 30, 2023 | -3.79 |
| Mar 31, 2023 | -2.17 |
| Dec 31, 2022 | 1.79 |
| Sep 30, 2022 | -2.71 |
| Jun 30, 2022 | -3.07 |
| Mar 31, 2022 | -2.43 |
| Dec 31, 2021 | -4.03 |
| Sep 30, 2021 | -3.94 |
| Jun 30, 2021 | -2.06 |